Mediation of β-Endorphin by the Isoflavone Puerarin to Lower Plasma Glucose in Streptozotocin-Induced Diabetic Rats

Abstract

We investigate the mechanism(s) of plasma glucose lowering action of puerarin in streptozotocin-induced diabetic rats (STZ-diabetic rats). Puerarin at the effective dosage to lower higher plasma glucose increased plasma β-endorphin-like immunoreactivity (BER) in STZ-diabetic rats. Both effects of puerarin were abolished by the pretreatment with prazosin. Also, puerarin enhanced BER release from isolated rat adrenal medulla in a concentration-dependent manner that can be abolished by prazosin. Moreover, bilateral adrenalectomy in STZ-diabetic rats eliminated the actions of puerarin including the plasma glucose lowering effect and plasma BER elevating effect. In addition, naloxone and naloxonazine inhibited the plasma glucose lowering action of puerarin. Unlike in wild-type diabetic mice, puerarin failed to lower the plasma glucose in opioid μ-receptor knockout diabetic mice. In conclusion, our results suggest that puerarin may activate α₁-adrenoceptors on the adrenal gland to enhance the secretion of β-endorphin to result in a decrease of plasma glucose in STZ-diabetic rats.

Key words

Puerarin - streptozotocin-induced diabetic rats - β-endorphin - α₁-adrenoceptors - opioid μ-receptors

References

• 1 Lopez-Candales A. Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy.  J Med. 2001;  32 283-300
• 2 Kaufman P B, Duke J A, Brielmann H, Boik J, Hoyt J E. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health.  J Altern Complement Med. 1997;  3 7-12
• 3 Kim D H, Yu K U, Bae E A, Han M J. Metabolism of puerarin and daidzin by human intestinal bacteria and their relation to in vitro cytotoxicity.  Biol Pharm Bull. 1998;  21 628-30
• 4 Shen Z F, Xie M Z. Hypoglycemic effect of the combined use of puerarin and aspirin in mice.  Acta Pharm Sin. 1985;  20 863-6
• 5 Fan L L, O’Keefe D D, Powell W J Jr. Effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia.  Acta Pharm Sin. 1984;  19 801-7
• 6 Hsu F L, Liu I M, Kuo D H, Chen W C, Su H C, Cheng J T. Antihyperglycemic Effect of Puerarin in Streptozotocin-Induced Diabetic Rats.  J Nat Prod. 2003;  66 788-92
• 7 Liu I M, Chi T C, Chen Y C, Lu F H, Cheng J T. Activation of opioid μ-receptor by loperamide to lower plasma glucose in streptozotocin-induced diabetic rats.  Neurosci Lett. 1999;  265 183-6
• 8 Cheng J T, Liu I M, Chi T C, Tzeng T F, Lu F H, Chang C J. Plasma glucose lowering effect of tramadol in streptozotocin-induced diabetic rats.  Diabetes. 2001;  50 2815-21
• 9 Cheng J T, Liu I M, Tzeng T F, Tsai C C, Lai T Y. Plasma glucose lowering effect of β-endorphin in streptozotocin-induced diabetic rats.  Horm Meta Res. 2002;  34 570-6
• 10 Cheng J T, Liu I M, Kuo D H, Lin M T. Stimulatory effect of phenylephrine on the secretion of β-endorphin from rat adrenal medulla in vitro .  Auton Neurosci Basic & Clinic. 2001;  93 31-5
• 11 Hsu H H, Chang C K, Su H C, Liu I M, Cheng J T. Stimulatory effect of puerarin on alpha1A-adrenoceptor to increase glucose uptake into cultured C2C12 cells of mice.  Planta Med. 2002;  68 999-1003
• 12 Loh H H, Liu H C, Cavalli A, Yang W, Chen Y F, Wei L N. Opioid μ receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality.  Mol Brain Res. 1998;  54 321-6
• 13 Liu I M, Chi T C, Shiao G C, Lin M T, Cheng J T. Loss of plasma glucose lowering response to cold stress in opioid mu-receptor knock-out diabetic mice.  Neurosci Lett. 2001;  307 81-4
• 14 Vatta M S, Presas M F, Bianciotti G, Rodriguez-Fermepin M, Ambros R, Fernandez B E. B and C types natriuretic peptides modify norepinephrine uptake and release in the rat adrenal medulla.  Peptides. 1997;  18 1483-9
• 15 Suzuki H, Zweifach B W, Forrest M J, Schmid-Schönbein G W. Modification of leukocyte adhesion in spontaneously hypertensive rats by adrenal corticosteroids.  J Leukoc Biol. 1995;  57 20-6
• 16 Wasserman D H, Zinman B. Exercise in individuals with IDDM.  Diabetes Care. 1994;  17 924-37
• 17 Arefolov V A, Dmitriev A D, Tennov A V, Val’dman A V. Detection of the pro-opiomelanocortin peptide fragments-beta-endorphin and ACTH-in the adrenals of rats and mice by immunohistochemistry.  Biull Eksp Biol Med. 1986;  101 445-7
• 18 Goldstein A. Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors.  Trends Pharmacol Sci. 1987;  8 456-9
• 19 Pasternak G W. Pharmacological mechanisms of opioid analgesics.  Clin Neuropharmacol. 1993;  16 1-18